NCT06690710View on ClinicalTrials.gov

FiH Safety and Feasibility Study Assessing Intra-articular Administration of aeGF in Patients With Knee Osteoarthritis

PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 14, 2025

Primary Completion Date

February 1, 2027

Study Completion Date

February 1, 2028

Conditions

Osteoarthritis, Knee

Interventions

BIOLOGICAL

allogeneic engineered Gingival Fibroblasts (aeGF)

single intra-articular injection of the study drug (aeGF) in the knee joint

Trial Locations (1)

OX3 7LD

RECRUITING

Oxford University Hospitals NHS Foundation Trust (Nuffield Orthopaedic Centre, Oxford), Oxford

All Listed Sponsors

collaborator

TFS Trial Form Support

INDUSTRY

collaborator

Boston Imaging Core Lab

UNKNOWN

lead

Scarcell Therapeutics S.A.S.

INDUSTRY

NCT06690710 - FiH Safety and Feasibility Study Assessing Intra-articular Administration of aeGF in Patients With Knee Osteoarthritis | Biotech Hunter | Biotech Hunter